Adage Capital Partners
CVS icon

Adage Capital Partners’s CVS Health CVS Stock Holding History

Adage Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115M Sell
1,596,630
-124,636
-7% -$9.6M 0.18% 111
2025
Q4 		$137M Sell
1,721,266
-150,133
-8% -$11.8M 0.21% 94
2025
Q3 		$141M Buy
1,871,399
+261,800
+16% +$17.9M 0.22% 79
2025
Q2 		$111M Buy
1,609,599
+485,825
+43% +$31.9M 0.19% 104
2025
Q1 		$76.1M Sell
1,123,774
-69,000
-6% -$4.13M 0.14% 146
2024
Q4 		$53.5M Buy
1,192,774
+26,738
+2% +$1.5M 0.09% 205
2024
Q3 		$73.3M Buy
1,166,036
+814,479
+232% +$47.5M 0.13% 163
2024
Q2 		$20.8M Sell
351,557
-491,355
-58% -$30.7M 0.04% 424
2024
Q1 		$67.2M Sell
842,912
-175,149
-17% -$13.4M 0.13% 172
2023
Q4 		$80.4M Sell
1,018,061
-443,444
-30% -$31.6M 0.17% 139
2023
Q3 		$102M Buy
1,461,505
+184,231
+14% +$13.1M 0.23% 104
2023
Q2 		$88.3M Buy
1,277,274
+314,900
+33% +$22.4M 0.19% 129
2023
Q1 		$71.5M Sell
962,374
-374,100
-28% -$31.4M 0.16% 157
2022
Q4 		$125M Sell
1,336,474
-1,100
-0.1% -$106K 0.3% 75
2022
Q3 		$128M Sell
1,337,574
-28,100
-2% -$2.78M 0.32% 65
2022
Q2 		$127M Sell
1,365,674
-4,900
-0.4% -$478K 0.29% 65
2022
Q1 		$139M Sell
1,370,574
-36,100
-3% -$3.79M 0.26% 81
2021
Q4 		$145M Sell
1,406,674
-4,700
-0.3% -$434K 0.26% 80
2021
Q3 		$120M Sell
1,411,374
-21,200
-1% -$1.78M 0.24% 91
2021
Q2 		$120M Sell
1,432,574
-22,800
-2% -$1.87M 0.23% 87
2021
Q1 		$109M Buy
1,455,374
+1,900
+0.1% +$138K 0.22% 95
2020
Q4 		$99.3M Sell
1,453,474
-19,800
-1% -$1.29M 0.22% 100
2020
Q3 		$86M Sell
1,473,274
-35,500
-2% -$2.21M 0.22% 99
2020
Q2 		$98M Buy
1,508,774
+16,700
+1% +$1.05M 0.25% 88
2020
Q1 		$88.5M Sell
1,492,074
-23,200
-2% -$1.55M 0.26% 92
2019
Q4 		$113M Sell
1,515,274
-57,500
-4% -$4.04M 0.28% 91
2019
Q3 		$99.2M Sell
1,572,774
-14,600
-0.9% -$865K 0.24% 102
2019
Q2 		$86.5M Sell
1,587,374
-36,600
-2% -$1.97M 0.22% 119
2019
Q1 		$87.6M Buy
1,623,974
+4,200
+0.3% +$259K 0.22% 117
2018
Q4 		$106M Buy
+1,619,774
New +$121M 0.29% 96
2017
Q4 		– Sell
-1,838,583
Closed -$150M – 708
2017
Q3 		$150M Buy
1,838,583
+584,793
+47% +$46.3M 0.36% 67
2017
Q2 		$101M Sell
1,253,790
-8,942
-0.7% -$706K 0.25% 110
2017
Q1 		$99.1M Sell
1,262,732
-140,806
-10% -$11.2M 0.25% 108
2016
Q4 		$111M Sell
1,403,538
-156,200
-10% -$12.6M 0.3% 82
2016
Q3 		$139M Sell
1,559,738
-44,600
-3% -$4.21M 0.38% 69
2016
Q2 		$154M Sell
1,604,338
-159,500
-9% -$15.9M 0.42% 70
2016
Q1 		$183M Buy
1,763,838
+96,600
+6% +$9.39M 0.5% 51
2015
Q4 		$163M Sell
1,667,238
-354,200
-18% -$34.7M 0.43% 62
2015
Q3 		$195M Sell
2,021,438
-60,800
-3% -$6.39M 0.54% 40
2015
Q2 		$218M Sell
2,082,238
-30,000
-1% -$3.07M 0.54% 33
2015
Q1 		$218M Buy
2,112,238
+226,000
+12% +$22.9M 0.53% 32
2014
Q4 		$182M Buy
1,886,238
+123,300
+7% +$10.9M 0.44% 53
2014
Q3 		$140M Sell
1,762,938
-20,000
-1% -$1.58M 0.35% 74
2014
Q2 		$134M Sell
1,782,938
-34,000
-2% -$2.57M 0.35% 79
2014
Q1 		$136M Sell
1,816,938
-228,400
-11% -$16.1M 0.37% 66
2013
Q4 		$146M Buy
2,045,338
+300,800
+17% +$19.3M 0.39% 61
2013
Q3 		$99M Buy
1,744,538
+140,950
+9% +$8.4M 0.28% 97
2013
Q2 		$91.7M Buy
+1,603,588
New +$92.9M 0.28% 94

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Adage Capital Partners's CVS Position: Q1 2026 in Review

Adage Capital Partners reduced its CVS Health (CVS) stake by 7.2% in Q1 2026, selling an estimated $9.6M and leaving 1,596,630 shares worth $115M. The position accounts for 0.18% of the portfolio, ranked #111.

Adage Capital Partners first reported a position in CVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $218M in Q2 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Adage Capital Partners held 1,596,630 shares of CVS Health worth $115M as of Q1 2026.
  • Adage Capital Partners sold 124,636 CVS Health shares in Q1 2026, an estimated $9.6M.
  • CVS Health made up 0.18% of Adage Capital Partners's portfolio in Q1 2026, its #111 holding.
  • Adage Capital Partners first reported a position in CVS Health in Q2 2013 and has held it in 48 quarters since.
  • Adage Capital Partners's CVS Health position peaked at $218M in Q2 2015.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.